Geschäft · 1.6.19981 Min. Lesezeit
Implantation or Injectable Dosage Form New Animal Drugs; Lufenuron Suspension
Lokale automatische Übersetzung · Originalsprache der Quelle
Zusammenfassung
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a new animal drug application (NADA) filed by Novartis Animal Health US, Inc. The NADA provides for subcutaneous use of lufenuron suspension in cats for control of flea populations.